
Global Cord Blood Corporation CO
Quarterly report 2022-Q1
added 05-23-2026
Global Cord Blood Corporation P/CF Ratio 2011-2026 | CO
Annual P/CF Ratio Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.495 | 0.771 | 0.754 | 0.712 | 0.866 | 1.17 | 0.723 | 0.719 | 0.813 | 0.479 | 0.536 | 0.984 | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.17 | 0.479 | 0.752 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
-5.18 | $ 17.69 | 3.39 % | $ 544 M | ||
|
Guardant Health
GH
|
-72.7 | $ 119.49 | 0.45 % | $ 15 B | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.8 | -1.1 % | $ 7.96 M | ||
|
Agilent Technologies
A
|
28.3 | $ 115.43 | 0.44 % | $ 35.1 B | ||
|
Celcuity
CELC
|
-35 | $ 133.94 | -3.1 % | $ 6.26 B | ||
|
Illumina
ILMN
|
19.6 | $ 145.04 | 0.44 % | $ 23.1 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 9.47 | 86.69 % | $ 12.6 M | ||
|
Castle Biosciences
CSTL
|
7.33 | $ 19.68 | -2.36 % | $ 570 M | ||
|
Aspira Women's Health
AWH
|
-0.0975 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.0826 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 21.37 | -1.2 % | $ 1.14 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 114.69 | -1.79 % | $ 9.46 B | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 101.26 | -1.69 % | $ 6.83 B | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-23.5 | - | - | $ 7.1 B | ||
|
Mettler-Toledo International
MTD
|
29.7 | $ 1 105.63 | 0.25 % | $ 22.8 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
284 | $ 9.32 | 1.03 % | $ 1.19 B | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 19.06 | -0.1 % | $ 427 M | ||
|
Natera
NTRA
|
-12.3 | $ 200.39 | -1.38 % | $ 19.7 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 156.8 | -2.18 % | $ 7.77 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Personalis
PSNL
|
-5.75 | $ 9.09 | 7.26 % | $ 811 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 430.53 | -0.53 % | $ 12.4 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 3.87 | 1.18 % | $ 358 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 26.9 | -0.19 % | $ 25.5 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 6.39 | 0.79 % | $ 267 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
44.5 | - | - | $ 2.69 B | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 64.55 | 6.57 % | $ 3.86 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.43 | -2.41 % | $ 5.58 M | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 259.74 | -0.1 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 448.63 | 0.08 % | $ 169 B | ||
|
Trinity Biotech plc
TRIB
|
-46.3 | $ 0.66 | 10.27 % | $ 237 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
30.1 | $ 340.73 | -0.48 % | $ 20.3 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.18 | 3.15 % | $ 1.99 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 193.43 | -0.91 % | $ 21.5 B |